Etoposide (VP 16-213) induced hepatitis. Report of three cases following standard-dose treatments.
Acute hepatitis is a potential, although rare, complication following administration of high doses of Etoposide (VP 16-213). We report three cases of severe hepatocellular necrosis following administration of standard doses of this antineoplastic agent.